Invus Financial Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Invus Financial Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$7.12M	Hold	1,007,575	–	–	7.98%	4
2024 Q1	$13.9M	Hold	1,007,575	–	–	11.01%	4
2023 Q4	$9.27M	Hold	1,007,575	–	–	7.25%	5
2023 Q3	$6.1M	Hold	1,007,575	–	–	3.82%	6
2023 Q2	$7.82M	Hold	1,007,575	–	–	4.18%	8
2023 Q1	$5.74M	Hold	1,007,575	–	–	3.74%	7
2022 Q4	$5.93M	Hold	1,007,575	–	–	3.16%	7
2022 Q3	$3.22M	Hold	1,007,575	–	–	1.77%	8
2022 Q2	$4.51M	Hold	1,007,575	–	–	2.73%	7
2022 Q1	$5.38M	Hold	1,007,575	–	–	2.39%	7
2021 Q4	$14.8M	Hold	1,007,575	–	–	4.5%	7
2021 Q3	$21.1M	Hold	1,007,575	–	–	5.64%	7
2021 Q2	$17.8M	Hold	1,007,575	–	–	3.55%	7
2021 Q1	$24.7M	Hold	1,007,575	–	–	5.66%	6
2020 Q4	$34.1M	Sell	1,007,575 -1	-0%	-$29	14.26%	5
2020 Q3	$25.2M	Hold	1,007,576	–	–	12.12%	5
2020 Q2	$34M	Buy	+1,007,576	New	+$32.2M	12.28%	4

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return